Proteomics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, UK, Germany, China, Japan - Size and Forecast 2023-2027

Proteomics Market Forecast 2023-2027

Proteomics Market size is estimated to grow by USD 21.74 billion at a CAGR of 13.05% between 2022 and 2027. Increasing advances in proteomics research are a major factor driving market growth. The market is primarily driven by the rapid advances in proteomics research. Proteomics involves studying the complete set of proteins expressed by cells, tissues, or organisms. Recent years have seen remarkable progress in the field, fueled by advancements in technologies like mass spectrometry, chromatography, and bioinformatics. These innovations have led to the development of novel methods for protein identification, quantification, and characterization, as well as deeper insights into protein functions in disease and normal physiology.

Consequently, the demand for proteomics products and services has surged, propelling the growth of the global proteomics market.Furthermore, the adoption of enhancements such as parallel sample processing, advanced spotting techniques, and miniaturization approaches has attracted researchers to explore proteomics for various applications like drug discovery, diagnosis, and protein production. These factors are expected to drive market growth in the forecast period. 

What will be the Size of the Proteomics Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Dynamics and Customer Landscape

 

The proteomics industry is experiencing significant growth driven by advancements in technology and research. Scientists utilize various proteomic techniques such as mass spectrometry to analyze proteins and identify potential biomarkers for applications in drug discovery and diagnostics. With proteomic profiling and analysis, researchers can gain insights into protein expression patterns, leading to a deeper understanding of disease mechanisms. Additionally, the development of proteomic tools and databases facilitates the organization and interpretation of vast proteomic data, driving further innovation in the field. These trends indicate promising opportunities for the market in the coming years.There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Market Drivers

The emergence of precision proteomics is a major factor driving the market growth. Precision proteomics is a key factor propelling the global proteomics industry. It employs advanced analytical tools to accurately identify and quantify proteins in complex biological samples. This approach enhances our understanding of biological systems and disease mechanisms, enabling the development of targeted therapies. Precision proteomics also facilitates the discovery of disease biomarkers and potential drug targets. Recent advancements in mass spectrometry, bioinformatics, and sample preparation techniques have fueled the growth of precision proteomics. The increasing prevalence of chronic diseases and the demand for personalized treatments further contribute to its adoption. As precision medicine evolves, proteomics will continue to play a crucial role in unraveling disease biology and advancing drug development, ensuring the market's growth in the forecast period.

Significant Market Trends

The emergence of label-free quantification techniques is a major trend in the market. The market has witnessed notable trends, including the rise of label-free quantification techniques. Label-free quantification utilizes mass spectrometry-based methods to measure proteins without chemical or isotopic labels. This approach is gaining popularity due to its advantages, including enhanced accuracy, reproducibility, and cost-effectiveness, as well as the ability to analyze larger sample sizes. Furthermore, label-free quantification avoids potential artifacts caused by labeling interference.

Other trends in the market include the increased use of high-throughput technologies, greater adoption of proteomics in drug discovery, and the integration of proteomics with omics technologies like genomics and metabolomics. The market is anticipated to continue growing as personalized medicine gains demand, proteomics technology advances, and proteomics finds application in diverse fields such as drug discovery, clinical diagnostics, and agricultural research.

Major Market Challenges

Experimental challenges in protein structure determination is a major factor hindering the market growth. One of the major challenges in the market is the experimental difficulties associated with determining protein structures. Protein structure determination is a complex process that often requires multiple techniques and expertise. Current methods, like X-ray crystallography and NMR spectroscopy, have limitations and may not always be successful. Large, multi-domain proteins, membrane proteins, and proteins with flexible regions pose particular challenges. Additionally, detecting post-translational modifications (PTMs) and the cost and time required for protein structure determination are significant obstacles.

These challenges hinder the growth of the proteomics market. Overcoming them necessitates developing new techniques, improving existing methods, and fostering interdisciplinary collaboration. The inherent instability and flexibility of proteins present challenges across various proteomics aspects, impeding the market's progress in the forecast period.

Buy Now Full Report and Discover More

Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global  Market Customer Landscape

Proteomics Market Segmentation by Product, End-User, and Geography Analysis

Technavio has segmented the market into Product, End-user, and Geography.

• The product segment is classified into reagents, instruments, and services
• The end-user segment is classified into clinical diagnostics, drug discovery, and others
• The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

Product Analysis

The market share growth by the reagents segment will be significant during the forecast period. Some examples of reagents used in proteomics include antibodies, buffers and solutions, enzymes, kits, and beads and columns. 

Get a glance at the market contribution of various segments View a PDF Sample

The reagents segment was valued at USD 8.22 billion in 2017 and continued to grow until 2021. Regents are used for protein purification and isolation based on specific properties, such as size, charge, or affinity. Key factors, such as high availability, low price, and the generation of fast and reproducible results, are expected to drive the demand for reagents from researchers during the forecast period. This, in turn, drives the growth of the reagents segment of the  market. 

End-User Analysis

Proteomic technologies are revolutionizing clinical diagnostics by enhancing the detection, diagnosis, and monitoring of diseases. These advanced methods offer greater accuracy and sensitivity compared to traditional approaches. It  enables the identification of disease biomarkers, personalized treatments, and therapy response monitoring. Clinical applications include cancer diagnosis, cardiovascular disease management, infectious disease detection, neurological disease monitoring, and autoimmune disease management. The growing demand for personalized medicine and the prevalence of chronic diseases drive the expansion of the clinical diagnostics segment. Monoclonal antibodies, particularly in immunoassays like ELISA, play a significant role in disease detection. ELISA, known for its sensitivity and specificity, aids in diagnosing allergies, anemia, autoimmunity, fertility issues, infectious diseases, and inflammation. The rising adoption in diagnostics and advanced technologies fuels the segment's growth in the forecast period.

Techniques play a vital role in the drug discovery segment, aiding in the identification of potential drug targets and the development of new drugs. It  enables the identification of disease-related proteins and their interactions with drugs. This segment is projected to experience rapid growth due to the demand for innovative drugs that can effectively treat diverse diseases. Its a techniques offer unique insights into disease mechanisms and drug targets that other methods cannot provide. Moreover, it  finds applications in clinical diagnostics, enabling the identification of disease biomarkers, personalized treatment plans, and disease monitoring. Market is poised for sustained growth as technology advances and the need for novel drugs and diagnostic tools increases.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period.

The growth of the market in North America is attributed to factors such as the presence of a large biotechnology industry. The increasing funding for proteomics research, the rising focus on personalized medicine, and the growing prevalence of chronic diseases are also driving the growth of the regional market. The US is the largest contributor to market growth in North America due to the high concentration of major players and the presence of well-established healthcare infrastructure. The region is also witnessing significant investments in protein research by asset management firms with strong financials. Extensive research is being conducted on protein crystallization and crystallography, as they help in the structural determination of proteins. These factors are contributing to the growth of the market in the region.

Buy Now Full Report and Discover More

Key Proteomics Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Thermofisher- The company offers proteomics and protein analysis products such as Lumit Immunoassays, Mass Spectrometry, bioluminescent HiBiT Protein Tagging System, and HaloTag polyhistidine protein purification system.

• Agilent Technologies Inc.
• Applied Biomics Inc.
• Bio Rad Laboratories Inc.
• Biognosys AG
• Bruker Corp.
• CellCarta Biosciences Inc.
• Creative Proteomics
• DiaSorin Spa
• F. Hoffmann La Roche Ltd.
• Geno Technology Inc.
• HORIBA Ltd.
• Merck KGaA
• Olink Holding AB
• Perkin Elmer Inc.
• Promega Corp.
• QIAGEN NV
• Thermo Fisher Scientific Inc.
• Waters Corp.
• Cell Signaling Technology Inc.
• Illumina Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

The market is experiencing significant growth driven by advancements in proteomic techniques and proteomic research. With the increasing demand for personalized medicines and the need for understanding protein expression in diseases, the market is witnessing rapid developments in proteomic profiling and proteomic analysis. Collaborations between equipment manufacturers like Waters Corporation and Bruker Corporation are further fueling the expansion of the  industry. Additionally, the availability of proteomic databases and proteomic tools is enhancing proteomic research capabilities, driving the overall  market growth.

The field of proteomics encompasses a wide range of techniques and processes aimed at understanding the proteome, the entire set of proteins expressed by an organism or system. One such essential technique is electrophoresis, which separates proteins based on their size and charge. Through advancements in proteomic services and consumables such as gel strips, researchers can analyze proteins with greater speed and accuracy. These developments are crucial in various applications, including drug design, where understanding protein interactions and functions is essential. Regions like Brazil are witnessing significant growth in the markets, driven by factors such as increasing population and the rising demand for personalized healthcare tailored to individual patients.

Segment Overview

The  market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

• Product Outlook
  • Reagents
  • Instruments
  • Services
• End-user Outlook
  • Clinical diagnostics
  • Drug discovery
  • Others
• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of World (ROW)
    • Australia
    • Argentina
    • Rest of the world

Market Scope
Report Coverage	Details
Page number	170
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 13.05%
Market growth 2023-2027	USD 21.74 billion
Market structure	Fragmented
YoY growth 2022-2023(%)	12.53
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 39%
Key countries	US, UK, Germany, China, and Japan
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	Agilent Technologies Inc., Applied Biomics Inc., Bio Rad Laboratories Inc., Biognosys AG, Bruker Corp., CellCarta Biosciences Inc., Creative Proteomics, DiaSorin Spa, F. Hoffmann La Roche Ltd., Geno Technology Inc., HORIBA Ltd., Merck KGaA, Olink Holding AB, Perkin Elmer Inc., Promega Corp., QIAGEN NV, Thermo Fisher Scientific Inc., Waters Corp., Cell Signaling Technology Inc., and Illumina Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our market forecasting report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research and Growth Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2023 and 2027
• Precise estimation of the size of the  market size and its contribution of the market in focus to the parent market
• Detailed analysis of customer landscape covering diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
• Companies landscape comparing criticality of inputs and factors of differentiation
• Exclusive Matrix on companies position and classification
• Accurate predictions about upcoming market trends and changes in consumer behavior
• Growth of the market growth analysts across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of  market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch